ergonovine has been researched along with Cardiac Arrest, Sudden in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okura, T; Sakaue, T; Sueda, S | 1 |
| Sueda, S | 1 |
| Aihara, N; Kamakura, S; Kurita, T; Noda, T; Satomi, K; Shimizu, W; Suyama, K; Taguchi, A | 1 |
| Iskandrian, AS; Mette, SA; Roberts, SA; Schalet, BD; Segal, BL; Tecce, MA | 1 |
| Hattemer, C; Lenihan, D; Ritchie, ME | 1 |
| Hauer, RN; Peters, RH; Robles de Medina, EO; Wever, EF | 1 |
| Chevalier, DP; Touboul, DP | 1 |
| Castellanos, A; Cox, MM; deMarchena, E; Interian, A; Kessler, KM; Mallon, SM; Myerburg, RJ | 1 |
8 other study(ies) available for ergonovine and Cardiac Arrest, Sudden
| Article | Year |
|---|---|
Spasm Provocation Tests under Medication May Help Decide on Medical or Mechanical Therapy in Patients with Aborted Sudden Cardiac Death due to Coronary Spasm.
Topics: Aged; Coronary Vasospasm; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrocardiography; Ergonovine; Humans; Injections, Intra-Arterial; Japan; Male; Middle Aged; Oxytocics; Practice Guidelines as Topic; Retrospective Studies | 2020 |
Pharmacological spasm provocation testing in 2500 patients: provoked spasm incidence, complications and cardiac events.
Topics: Acetylcholine; Acute Coronary Syndrome; Aged; Angina Pectoris; Coronary Vasospasm; Death, Sudden, Cardiac; Ergonovine; Female; Heart Disease Risk Factors; Heart Function Tests; Humans; Incidence; Male; Middle Aged; Predictive Value of Tests; Recurrence; Retrospective Studies; Risk Assessment; Time Factors; Vasoconstrictor Agents; Ventricular Fibrillation | 2020 |
ST-segment elevation and ventricular fibrillation without coronary spasm by intracoronary injection of acetylcholine and/or ergonovine maleate in patients with Brugada syndrome.
Topics: Acetylcholine; Adult; Aged; Bundle-Branch Block; Coronary Vasospasm; Coronary Vessels; Death, Sudden, Cardiac; Dose-Response Relationship, Drug; Electrocardiography; Ergonovine; Female; Heart Conduction System; Humans; Injections, Intravenous; Japan; Male; Middle Aged; Syndrome; Vasodilator Agents; Ventricular Fibrillation | 2002 |
Sudden cardiac death from coronary artery spasm in a healthy subject.
Topics: Adult; Cardiac Catheterization; Coronary Angiography; Coronary Vasospasm; Death, Sudden, Cardiac; Diagnosis, Differential; Ergonovine; Exercise Test; Humans; Male; Tomography, Emission-Computed, Single-Photon | 1994 |
Ergonovine-testing-directed therapy and long-term outcome of sudden-death survivors with no apparent heart disease.
Topics: Adult; Calcium Channel Blockers; Coronary Angiography; Coronary Vasospasm; Death, Sudden, Cardiac; Ergonovine; Female; Humans; Male; Middle Aged; Survivors | 1998 |
Low prevalence of coronary artery spasm in patients with normal coronary angiograms and unexplained ventricular fibrillation.
Topics: Adult; Coronary Angiography; Coronary Vasospasm; Death, Sudden, Cardiac; Electrocardiography; Electrocardiography, Ambulatory; Ergonovine; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Risk Factors; Ventricular Fibrillation | 1998 |
Calcium-channel blockers and cardiac arrest.
Topics: Calcium Channel Blockers; Coronary Vasospasm; Death, Sudden, Cardiac; Ergonovine; Humans | 1999 |
Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm.
Topics: Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Calcium Channel Blockers; Coronary Disease; Coronary Vasospasm; Death, Sudden, Cardiac; Electrocardiography; Ergonovine; Female; Humans; Male; Middle Aged; Prospective Studies | 1992 |